NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Genre Technical Report Remove constraint Genre: Technical Report Recently Added Within 6 Months Remove constraint Recently Added: Within 6 Months Dates by Range 2000 and later Remove constraint Dates by Range: 2000 and later

Search Results

101. Belimumab and voclosporin for lupus nephritis: effectiveness and value : final report

102. Treatments for anemia in chronic kidney disease: effectiveness and value : final evidence report

103. Bempedoic acid and inclisiran for patients with heterozygous familial hypercholesterolemia and for secondary prevention of ASCVD: Effectiveness and value : final report

105. Labs with questionably high billing for additional tests alongside COVID-19 tests warrant further scrutiny

110. Public health: Leading practices could help guide HHS reform efforts to address risk and improve preparedness : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

112. Federal research: NIH could take additional actions to manage risks involving foreign subrecipients : report to congressional requesters

116. Medicaid: CMS oversight and guidance could improve Recovery Audit Contractor program : report to congressional requesters

117. USAID: Management improvements needed to better meet global health mission : report to the Chairman, Committee on Foreign Relations, U.S. Senate

118. Indian Health Service: Actions needed to improve use of data on adverse events : report to congressional requesters

120. Defense health care: Additional assessments needed to determine effects of active duty medical personnel reductions : report to congressional committees

122. VA health care: Office of the Medical Inspector should strengthen oversight of recommendations and assess performance : report to congressional requesters

123. Unwanted sexual behavior: improved guidance, access to care, and training needed to better address victims’ behavioral health needs : report to congressional requesters

125. CBO’s 2023 long-term budget projections: presentation at the American Enterprise Institute : methodologies in fiscal, economic, and health spending projections

126. Final evaluation of California’s Health Homes Program (HHP)

132. Consolidated Appropriations Act, 2023: Medicaid and CHIP provisions explained

136. Mixed results: state employee health plans face challenges, find opportunities to contain cost growth

142. Unwinding the Medicaid continuous coverage protection at the end of the COVID public health emergency: tips and best practices

143. Mississippi women of reproductive age face many barriers to good health

144. State fiscal incentives for Medicaid expansion continue after the end of public health emergency

146. An analysis of Georgia’s Section 1115 Medicaid Pathways to Coverage program

149. Evidence on the effectiveness of programs, models, and strategies to support employment outcomes of young adults on the autism spectrum: a review of the literature

150. How did the COVID-19 pandemic affect the education and employment of young people with disabilities?: findings from the Promoting Readiness of Minors in Supplemental Security Income (PROMISE) evaluation

151. Evaluation of the Maryland Total Cost of Care Model: quantitative-only report for the model’s first three years (2019 to 2021)

153. Promoting readiness of minors in Supplemental Security Income (PROMISE). Youth and family outcomes five years after enrollment

158. Data brief: sexual and reproductive health services among people with employer sponsored insurance

163. Gene therapies for sickle cell disease: final evidence report

164. Resmetirom and obeticholic acid for non-alcoholic steatohepatitis (NASH): final evidence report

165. Lecanemab for early Alzheimer’s disease: final evidence report

166. JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: effectiveness and value : final evidence report

167. Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: effectiveness and value : final evidence report

168. Tezepelumab for severe asthma: final report

169. Fezolinetant for moderate to severe vasomotor symptoms associated with menopause: effectiveness and value : final evidence report

170. Gene therapy for hemophilia B and an update on gene therapy for hemophilia A: effectiveness and value : final evidence report

171. Special assessment of outpatient treatments for COVID-19: nirmatrelvir/ritonavir (Paxlovid) health-benefit price benchmark update

172. Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pre-treated relapsed and refractory multiple myeloma: final report

173. Health care affordability improved between 2019 and 2022 under pandemic health coverage policies: findings from the Well-Being and Basic Needs Survey

177. Coverage and cost effects of Senators Merkley and Murphy’s Choose Medicare Act

179. Evaluating California’s efforts to address the commercial sexual exploitation of children

180. Employment and material hardship among adults with long COVID in December 2022

182. Advancing primary prevention in human services. Opportunities for people with lived experience

183. Advancing primary prevention in human services. Key considerations for policy designers and funding partners

184. Advancing primary prevention in human services. Key considerations for administrators and practitioners

185. Medicare Part B drugs: trends in spending and utilization, 2008-2021

186. Medicare Part D enrollee out-of-pocket spending: recent trends and projected impacts of the Inflation Reduction Act

187. Updated Medicare FFS telehealth trends by beneficiary characteristics, visit specialty, and state, 2019-2021

190. Does schooling improve cognitive abilities at older ages?: causal evidence from nonparametric bounds

194. Medicare payment policy for post-acute care in nursing homes

195. Expiration of the USDA Supplemental Nutrition Assistance Program (SNAP) emergency allotments: increased food insufficiency highlights inadequacy of SNAP benefits after thrifty food plan revisions

196. To protect and serve: clarifying the role of law enforcement in the emergency department

197. Effect of nudges to clinicians, patients, or both to increase statin prescribing: a cluster randomized clinical trial

199. CMS has opportunities to strengthen states’ oversight of Medicaid Managed Care Plans’ reporting of medical loss ratios